Prostate Cancer - Results from #180

PSMA PET/CT-based Atlas for Prostatic Bed Recurrence after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy Contouring Guidelines. February 13, 2023

Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial. February 13, 2023

Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study. February 13, 2023

Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations. February 13, 2023

Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial. February 13, 2023

Prevalence and Morbidity of Local Treatment-Related Side Effects in Metastatic Prostate Cancer Patients. February 13, 2023

Mark Cuban Pharmacy Could Save Billions on Prostate Cancer, Bladder Drugs February 10, 2023

Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. February 10, 2023

Impact of previous depression on the risk of suicide among prostate cancer patients. February 10, 2023

Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance. February 10, 2023

Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study. February 10, 2023

Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer. February 10, 2023

DNA methylation landscapes of prostate cancer brain metastasis are shaped by early driver genetic alterations. February 9, 2023

Impact of 3D printed models on quantitative surgical outcomes for patients undergoing robotic-assisted radical prostatectomy: a cohort study. February 9, 2023

Side-specific, Microultrasound-based Nomogram for the Prediction of Extracapsular Extension in Prostate Cancer. February 9, 2023

European Association of Urology Biochemical Recurrence Risk Groups after radical prostatectomy: external validation and identification of independent risk factors for progression and death: Grupos De Riesgo De Recidiva Bioquímica Tras Prostatectomía Radic February 9, 2023

Role, race, and place: Prostate cancer disparities in Patients' and Partners' health outcomes and psychosocial factors. February 9, 2023

Prostate Cancer Tumor Volume and Genomic Risk. February 8, 2023

The combination of prostate MRI PI-RADS scoring system and a genomic classifier is associated with pelvic lymph node metastasis at the time of radical prostatectomy. February 8, 2023

Prospective Long-term Health-related Quality of Life Outcomes After Surgery, Radiotherapy, or Active Surveillance for Localized Prostate Cancer. February 8, 2023

Page 10 of 1287